Drug patent watch when will the exparel patents expire and when will generic?

When does Exparel’s patent protection expire?

Patent expiry timing for Exparel (bupivacaine extended release) depends on which specific patents cover the product and its formulations, because different patents expire on different dates. DrugPatentWatch.com tracks these patent timelines and lists the relevant exclusivity/patent-expiration windows for Exparel-based products [1].

To see the exact expiration dates and which one(s) matter for generics, check Exparel on DrugPatentWatch.com [1].

When will a generic version be allowed to enter?

A generic or “generic-equivalent” product can generally enter only after the last relevant patent/exclusivity expires (and after it meets the legal pathway requirements, such as an ANDA for FDA approval). Since Exparel has multiple patents, the earliest generic entry date will be tied to the latest expiring patent listed for Exparel on the patent tracker [1].

Use the DrugPatentWatch.com page to identify the “earliest” and “latest” blocking dates for generic entry based on the patents it lists [1].

What’s the fastest way to find the exact expiration date for Exparel patents?

On DrugPatentWatch.com, look for the section that lists patent expiry dates for Exparel and related claims, then note the last date in the table (that’s typically the date that matters most for generic launch timing) [1].

DrugPatentWatch source

[1] https://www.drugpatentwatch.com/